Latest Funding News

Wisr Limited reports robust half-year growth with a 23% increase in its loan book and a 14% rise in revenue, setting the stage for expected cash profitability in the second half of FY26.

Riversgold has completed a significant drilling campaign at its Northern Zone within the Kalgoorlie Gold Project, with mining lease approval expected imminently. Collaborative efforts with MEGA Resources are accelerating plans for gold extraction in 2026.

Epiminder Limited has reported a $21.7 million loss for the half-year ending December 2025, alongside a successful $125 million IPO that fuels its commercialisation of the FDA-approved Minder epilepsy monitoring device.

Amplitude Energy has delivered a standout half-year performance with record gas production and a 246% jump in profit, while advancing key projects and strengthening its balance sheet.

Hiremii Limited has reported a record half-year revenue of $16.1 million, boosted by its acquisition of Prince Migration and advances in its AI recruitment platform. Despite a modest loss, the company is positioning itself for growth through technology innovation and strategic capital raises.

Catalina Resources has redefined its Beasley Creek project’s Flamingo target as a copper-gold volcanogenic massive sulphide system with an orogenic gold overprint, broadening its exploration scope. The company is preparing for its first modern drilling campaign to test this promising hybrid mineralisation model.

SSH Group Ltd has reported a remarkable turnaround in its half-year results, with revenue climbing 25% and net profit soaring over 3300%, driven by strong mining sector activity and operational efficiencies.

AuMEGA Metals has confirmed a $30 million oversubscribed financing led by Condire Investors to fund expanded drilling and exploration in Newfoundland. The capital raise is structured in two tranches, with the first closing expected in early March and the second pending shareholder approval.

NextEd Group Limited reported a 16.7% rise in underlying EBITDA and a 92% reduction in NPAT loss for H1 FY26, underpinned by AI integration and a strategic shift to higher-margin education segments.

Imricor Medical Systems saw a sharp 69.5% decline in revenue for 2025, driven by clinical trial impacts, yet narrowed its net loss to $25.3 million as it secured FDA clearance for key products post-year-end.

Tian An Australia Limited reported a remarkable turnaround in FY2025, posting a statutory profit of $23.4 million on $84 million revenue, driven by the completion of The Henley, Enfield project and a significant gain from debt restructuring.

Bapcor Limited has postponed its half-year financial results release to no later than 27 February 2026 and is seeking an extension of its trading suspension, hinting at a potential capital raising.